Clinical Trial

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

Study acronym: PIVOT
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
Trial Details
NCT Number NCT07226232
Lead Sponsor VA Office of Research and Development
Conditions Major Depression
Enrollment 240 participants
Start Date 2026-07-30
Primary Completion 2030-12-02 (estimated)
Study Completion 2031-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-05